EA200800142A1 - ФАРМАЦЕВТИЧЕСКИЕ ПРЕПАРАТЫ, СОДЕРЖАЩИЕ β-АГОНИСТ ДЛИТЕЛЬНОГО ДЕЙСТВИЯ, ДЛЯ ВВЕДЕНИЯ ПУТЕМ РАСПЫЛЕНИЯ - Google Patents

ФАРМАЦЕВТИЧЕСКИЕ ПРЕПАРАТЫ, СОДЕРЖАЩИЕ β-АГОНИСТ ДЛИТЕЛЬНОГО ДЕЙСТВИЯ, ДЛЯ ВВЕДЕНИЯ ПУТЕМ РАСПЫЛЕНИЯ

Info

Publication number
EA200800142A1
EA200800142A1 EA200800142A EA200800142A EA200800142A1 EA 200800142 A1 EA200800142 A1 EA 200800142A1 EA 200800142 A EA200800142 A EA 200800142A EA 200800142 A EA200800142 A EA 200800142A EA 200800142 A1 EA200800142 A1 EA 200800142A1
Authority
EA
Eurasian Patent Office
Prior art keywords
agonist
spraying
introduction
long
pharmaceutical preparations
Prior art date
Application number
EA200800142A
Other languages
English (en)
Other versions
EA013351B1 (ru
Inventor
Аннамария Сольяни Раскини
Алессандро Бодрия
Original Assignee
КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. filed Critical КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А.
Publication of EA200800142A1 publication Critical patent/EA200800142A1/ru
Publication of EA013351B1 publication Critical patent/EA013351B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Данное изобретение относится к жидкому фармацевтическому препарату, не содержащему пропеллент, в форме готового к применению препарата для введения путем распыления, содержащему водорастворимую соль β-агониста 8-гидрокси-5-[1-гидрокси-2-[[2-(4-метоксифенил)-1-метилэтил]амино]этил]-2(1Н)-хинолинона в качестве активного ингредиента. Данный активный ингредиент является химически стабильным в данном препарате, и указанный препарат обеспечивает адекватный срок хранения, подходящий для коммерческого распространения, хранения и применения.
EA200800142A 2005-08-01 2006-07-25 Фармацевтические препараты, содержащие бета-агонист длительного действия, для введения путем распыления EA013351B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05016664 2005-08-01
PCT/EP2006/007322 WO2007014673A2 (en) 2005-08-01 2006-07-25 Pharmaceutical formulations comprising a long-acting beta2-agonist for administration by nebulisation

Publications (2)

Publication Number Publication Date
EA200800142A1 true EA200800142A1 (ru) 2008-08-29
EA013351B1 EA013351B1 (ru) 2010-04-30

Family

ID=37564044

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200800142A EA013351B1 (ru) 2005-08-01 2006-07-25 Фармацевтические препараты, содержащие бета-агонист длительного действия, для введения путем распыления

Country Status (14)

Country Link
US (1) US20070065366A1 (ru)
EP (1) EP1915129B1 (ru)
JP (1) JP2009502997A (ru)
CN (1) CN101198313A (ru)
AR (1) AR055363A1 (ru)
AT (1) ATE446739T1 (ru)
AU (1) AU2006275137A1 (ru)
CA (1) CA2617286A1 (ru)
DE (1) DE602006010088D1 (ru)
EA (1) EA013351B1 (ru)
ES (1) ES2332290T3 (ru)
PE (1) PE20070414A1 (ru)
TW (1) TW200735870A (ru)
WO (1) WO2007014673A2 (ru)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2132179B1 (en) * 2007-02-28 2012-08-08 Cipla Limited Process for preparing isomers of carmoterol
WO2011015289A1 (en) 2009-08-04 2011-02-10 Chiesi Farmaceutici S.P.A. 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl] amino]ethyl]-2(1h)-quinolinone hemi-fumarate
AR081026A1 (es) * 2010-05-10 2012-05-30 Gilead Sciences Inc Analogos de quinolina y su uso en el tratamiento de enfermedades respiratorias
US8367829B2 (en) 2010-05-10 2013-02-05 Gilead Sciences, Inc. Bi-functional pyrazolopyridine compounds
WO2013063287A1 (en) * 2011-10-25 2013-05-02 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
US10350139B2 (en) 2011-10-25 2019-07-16 Corning Incorporated Pharmaceutical glass packaging assuring pharmaceutical sterility
AU2013271436B2 (en) 2012-06-07 2017-02-16 Corning Incorporated Delamination resistant glass containers
US10273048B2 (en) 2012-06-07 2019-04-30 Corning Incorporated Delamination resistant glass containers with heat-tolerant coatings
US9034442B2 (en) 2012-11-30 2015-05-19 Corning Incorporated Strengthened borosilicate glass containers with improved damage tolerance
US10117806B2 (en) 2012-11-30 2018-11-06 Corning Incorporated Strengthened glass containers resistant to delamination and damage
US9839579B2 (en) 2013-04-24 2017-12-12 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
US9849066B2 (en) 2013-04-24 2017-12-26 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
US9717648B2 (en) 2013-04-24 2017-08-01 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
US9603775B2 (en) 2013-04-24 2017-03-28 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
US9717649B2 (en) 2013-04-24 2017-08-01 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
US9707153B2 (en) 2013-04-24 2017-07-18 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
US9700486B2 (en) 2013-04-24 2017-07-11 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
US9707154B2 (en) 2013-04-24 2017-07-18 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
US9700485B2 (en) 2013-04-24 2017-07-11 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
US9707155B2 (en) 2013-04-24 2017-07-18 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
US9713572B2 (en) 2013-04-24 2017-07-25 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
CN107224427A (zh) * 2013-07-01 2017-10-03 成都苑东生物制药股份有限公司 一种格隆溴铵注射液组合物及其制备方法
MX2017002898A (es) 2014-09-05 2017-10-11 Corning Inc Artículos de vidrio y métodos para mejorar la confiabilidad de artículos de vidrio.
CN107001102A (zh) 2014-11-26 2017-08-01 康宁股份有限公司 用于生产强化且耐用玻璃容器的方法
CN110376313B (zh) * 2019-08-20 2022-06-07 广州健康元呼吸药物工程技术有限公司 一种检测富马酸福莫特罗或其相关制剂中杂质的方法
CN114452250A (zh) * 2021-12-14 2022-05-10 澳美制药(苏州)有限公司 盐酸丙卡特罗口服液及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8334494D0 (en) * 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
US20030215396A1 (en) * 1999-09-15 2003-11-20 Boehringer Ingelheim Pharma Kg Method for the production of propellant gas-free aerosols from aqueous medicament preparations
US6667344B2 (en) * 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
EP1452179A1 (en) * 2003-02-27 2004-09-01 CHIESI FARMACEUTICI S.p.A. Novel medicament combination of a highly potent long-lasting beta2-agonist and a corticosteroid
TWI359675B (en) * 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
CA2534120C (en) * 2003-07-31 2012-09-11 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising anticholinergics and a betamimetic
EP2484382A1 (en) * 2005-03-30 2012-08-08 Schering Corporation Medicament comprising a phosphodiesterase IV inhibitor in an inhalable form

Also Published As

Publication number Publication date
AR055363A1 (es) 2007-08-22
WO2007014673A3 (en) 2007-07-19
EP1915129A2 (en) 2008-04-30
JP2009502997A (ja) 2009-01-29
CN101198313A (zh) 2008-06-11
EP1915129B1 (en) 2009-10-28
DE602006010088D1 (de) 2009-12-10
AU2006275137A1 (en) 2007-02-08
US20070065366A1 (en) 2007-03-22
PE20070414A1 (es) 2007-05-11
WO2007014673A2 (en) 2007-02-08
ATE446739T1 (de) 2009-11-15
EA013351B1 (ru) 2010-04-30
TW200735870A (en) 2007-10-01
CA2617286A1 (en) 2007-02-08
ES2332290T3 (es) 2010-02-01

Similar Documents

Publication Publication Date Title
EA200800142A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ ПРЕПАРАТЫ, СОДЕРЖАЩИЕ β-АГОНИСТ ДЛИТЕЛЬНОГО ДЕЙСТВИЯ, ДЛЯ ВВЕДЕНИЯ ПУТЕМ РАСПЫЛЕНИЯ
EA200601578A1 (ru) Стабильные фармацевтические растворы для дозированных ингаляторов под давлением
CN1993118B (zh) 促进眼内渗透性的水性滴眼剂
EA200501108A1 (ru) Лекарство, содержащее сильнодействующий бета 2 - агонист длительного действия в комбинации с другими активными ингредиентами
RS52169B (en) STABLE LAKVINIMOD PREPARATIONS
ME01312B (me) Heteroaril supstituirani pirol0[2,3-b]piridini i pirol0 [ 2,3-b]pirimidini kao inhibitori janus kinaze
MX2009003042A (es) Composiciones farmaceuticas acuosas auto-preservadas.
RS52155B (en) PYROLO (3,4-c) PIRAZOL DERIVATIVE ACTIVE AS KINASE INHIBITORS
EA201291089A1 (ru) Способ получения фармацевтических препаратов, предназначенных для перорального введения, содержащих один или более активных ингредиентов, и содержащих их композиций
AR080875A1 (es) Inhibidores de la actividad de la proteina tirosina quinasa
ZA991572B (en) New salt forms of (2E)-5-amino-5-methylhex-2-enoic acid N-methyl-N-((1R)-1-(N-methyl-N-((1R)-1-(methylcarbamoyl)-2-phenylethyl)carbamoy L)-2-(2-naphthyl)ethyl)amide.
RS54420B1 (en) FORMULATION CONTAINING PHENYLAMINOPYRIMIDINE DERIVATIVE AS ACTIVE INGREDIENT
AR062112A1 (es) Derivados ciclicos como moduladores de la actividad del receptor de quimiocina
JP5964578B2 (ja) 抗菌・抗カビ組成物及び該組成物を含浸させたウエットワイパー
EP1757283A4 (en) MEDIUM FOR INCREASING ANTITUMOROUS EFFECTS, ANTITUMORAL AGENTS AND THERAPY PROCEDURES IN CANCER
EA200601531A1 (ru) Моногидрохлорид 8-гидрокси-5-[(1r)-1-гидрокси-2-[[(1r)-2-(4-метоксифенил)-1-метилэтил]амино]этил]-2(1h)-хинолинона в кристаллической форме и способ его получения
WO2008036855A3 (en) Self-preserved aqueous pharmaceutical compositions
WO2010030201A3 (en) Stable oral pharmaceutical composition containing a pharmaceutically acceptable salt of [(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2- [methyl(methylsulfonyl)amino]pyrimidine-5-yl] (3r, 5s) - 3,5 dihydroxyhept-6- enoic acid
WO2012074237A3 (ko) 도르졸라미드, 티몰롤 및 브리모니딘을 포함하는 안과용 액제 조성물
BR112021019388A2 (pt) Forma cristalina, e composição farmacêutica
UA92469C2 (en) Fumarate of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl amino benzonitrile
NO20064359L (no) Stabil farmasoytisk losningsformulering fror trykksatt doseringsinhalator
EA200500687A1 (ru) Применение дистронциевой соли 2-[n,n-ди(карбоксиметил)амино]-3-циано-4-карбоксиметилтиофен-5-карбоновой кислоты при получении лекарственных средств, предназначенных для лечения гастродуоденальной боли
UA88894C2 (ru) Стабильные фармацевтические композиции в виде растворов для ингаляторов с дозатором, которые находятся под давлением
NO20071720L (no) Fumarat av 4-[[4-[[4-(2-cyanoetenyl)-2,6-dimetylfenyl]amino]-2-pyrimidinyl]amino]benzonitril.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU